Tracking the Covid-19 Vaccine Rollout Around the Globe
What You Need To Know
The biggest vaccination effort in history has begun. This week, the U.K. was first to clear the use of a new shot from Pfizer Inc. and BioNTech SE, which the companies say stops 95% of Covid-19 infections. The U.S. will likely do the same, and a separate vaccine from Moderna Inc. is close behind.
By the end of 2020, tens of millions of people around the globe are expected to have been inoculated against the coronavirus. Next year, it will be billions more.
For the latest on the vaccine rollout, click here.
Key Coverage
By The Numbers
- 95% Efficacy of the best-performing Covid-19 vaccines so far
- 7.38 billion Number of vaccine doses contracted for distribution around the world
- 4 Number of vaccines with results from large trials
Why It Matters
Bloomberg is tracking nine of the most promising vaccines around the globe, from national procurement deals to shots in patients’ arms. By our count, more than one million people have been vaccinated and more than 7.85 billion doses have already been allotted.
That’s enough doses to cover half the world’s population—if they were distributed evenly. That, however, isn’t likely. Richer countries have hedged their bets with extensive supply deals, and some of the vaccines are inherently difficult to deliver to far-flung places. Some countries have struck their own paths. China and Russia got a head start by authorizing their vaccines in July before they’d even been tested. Including those, a total of five vaccines are now available, in limited quantities, in three countries.
As vaccine approval and rollout evolves, we’ll be following the progress and building new tools to better understand the data.
Timeline
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3 years ago U.K. Clears Pfizer-BioNTech Covid-19 Vaccine
-
-
3 years ago Moderna Seeks Clearance for Covid Vaccine
-
-
-
-
-
-
-
-
-
-
-
-
-
3 years ago Vaccine Diplomacy Is the New Space Race
-
-
-
-
-
-
